Wiltshire JJ, Drake TM, Uttley L, Balasubramanian SP. Systematic review of trends in the incidence rates of thyroid Cancer. Thyroid. 2016;26(11):1541–52. https://doi.org/10.1089/thy.2016.0100.
Article
PubMed
Google Scholar
Topstad D, Dickinson JA. Thyroid cancer incidence in Canada: a national cancer registry analysis. CMAJ Open. 2017;5(3):E612–6. https://doi.org/10.9778/cmajo.20160162.
Article
PubMed
PubMed Central
Google Scholar
Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338(5):297–306. https://doi.org/10.1056/NEJM199801293380506.
Article
CAS
PubMed
Google Scholar
Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients. World J Surg. 2018;42(3):615–22. https://doi.org/10.1007/s00268-018-4479-z.
Article
PubMed
PubMed Central
Google Scholar
Hardman JC, Smith JA, Nankivell P, Sharma N, Watkinson JC. Re-operative thyroid surgery: a 20-year prospective cohort study at a tertiary referral Centre. Eur Arch Otorhinolaryngol. 2015;272(6):1503–8. https://doi.org/10.1007/s00405-014-3068-5.
Article
PubMed
Google Scholar
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1–133. https://doi.org/10.1089/thy.2015.0020.
Article
PubMed
PubMed Central
Google Scholar
Goldner WS, Angell TE, McAdoo SL, Babiarz J, Sadow PM, Nabhan FA, et al. Molecular variants and their risks for malignancy in Cytologically indeterminate thyroid nodules. Thyroid. 2019;29(11):1594–605. https://doi.org/10.1089/thy.2019.0278.
Article
CAS
PubMed
PubMed Central
Google Scholar
Knauf JA, Sartor MA, Medvedovic M, Lundsmith E, Ryder M, Salzano M, et al. Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling. Oncogene. 2011;30(28):3153–62. https://doi.org/10.1038/onc.2011.44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, et al. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer. 2012;118(7):1764–73. https://doi.org/10.1002/cncr.26500.
Article
CAS
PubMed
Google Scholar
Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA. 2013;309(14):1493–501. https://doi.org/10.1001/jama.2013.3190.
Article
CAS
PubMed
PubMed Central
Google Scholar
Decaussin-Petrucci M, Descotes F, Depaepe L, Lapras V, Denier ML, Borson-Chazot F, et al. Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy. Cytopathology. 2017;28(6):482–7. https://doi.org/10.1111/cyt.12493.
Article
CAS
PubMed
Google Scholar
Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab. 2005;90(12):6373–9. https://doi.org/10.1210/jc.2005-0987.
Article
CAS
PubMed
Google Scholar
Zhao CK, Zheng JY, Sun LP, Xu RY, Wei Q, Xu HX. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for diagnosis of thyroid nodules: the influence of false-positive and false-negative results. Cancer Med. 2019;8(12):5577–89. https://doi.org/10.1002/cam4.2478.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rengyun L, Mingzhao X. TERT promoter mutations in thyroid Cancer. Endocr Relat Cancer Endocr Relat Cancer. 2016;23(3):R143–55.
Article
Google Scholar
Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer. 2013;20(4):603–10. https://doi.org/10.1530/ERC-13-0210.
Article
CAS
PubMed
PubMed Central
Google Scholar
McKelvey BA, Umbricht CB, Zeiger MA. Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review. Review Front Endocrinol (Lausanne). 2020;11:485. https://doi.org/10.3389/fendo.2020.00485.
Article
Google Scholar
Panebianco F, Nikitski AV, Nikiforova MN, Nikiforov YE. Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer. Cancer Med. 2019;8(13):5831–9. https://doi.org/10.1002/cam4.2467.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paulsson JO, Mu N, Shabo I, Wang N, Zedenius J, Larsson C, et al. TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours. Endocr Relat Cancer. 2018;25(7):723–33. https://doi.org/10.1530/ERC-18-0050.
Article
CAS
PubMed
Google Scholar
Censi S, Cavedon E, Bertazza L, Galuppini F, Watutantrige-Fernando S, De Lazzari P, et al. Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: a monocentric case series at a tertiary-level endocrinology unit. Front Endocrinol (Lausanne). 2017;8:273.
Article
Google Scholar
Tanaka A, Matsuse M, Saenko V, Nakao T, Yamanouchi K, Sakimura C, et al. TERT mRNA expression as a novel prognostic Marker in papillary thyroid carcinomas. Thyroid. 2019;29(8):1105–14. https://doi.org/10.1089/thy.2018.0695.
Article
CAS
PubMed
Google Scholar
Rivas AM, Nassar A, Zhang J, Casler JD, Chindris AM, Smallridge R, et al. ThyroSeq®V2.0 molecular testing: a cost-effective approach for the evaluation of indeterminate thyroid nodules. Endocr Pract. 2018;24(9):780–8. https://doi.org/10.4158/EP-2018-0212.
Article
PubMed
Google Scholar
Wang Z, Sun K, Jing C, Cao H, Ma R, Wu J. Comparison of droplet digital PCR and direct sanger sequencing for the detection of the BRAFV600E mutation in papillary thyroid carcinoma. J Clin Lab Anal. 2019 Jul;33(6):e22902. https://doi.org/10.1002/jcla.22902.
Article
CAS
PubMed
PubMed Central
Google Scholar
Biron VL, Kostiuk M, Isaac A, Puttagunta L, O'Connell DA, Harris J, et al. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction. Cancer. 2016;122(10):1544–51. https://doi.org/10.1002/cncr.29976.
Article
CAS
PubMed
Google Scholar
Fontanelli G, Baratè C, Ciabatti E, Guerrini F, Grassi S, Del Re M, et al. Real-time PCR and droplet digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms. Int J Lab Hematol. 2015;37(6):766–73. https://doi.org/10.1111/ijlh.12404.
Article
CAS
PubMed
Google Scholar
Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10(10):1003–5. https://doi.org/10.1038/nmeth.2633.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011;83(22):8604–10. https://doi.org/10.1021/ac202028g.
Article
CAS
PubMed
PubMed Central
Google Scholar
Isaac A, Jeffery CC, Seikaly H, Al-Marzouki H, Harris JR, O'Connell DA. Predictors of non-diagnostic cytology in surgeon-performed ultrasound guided fine needle aspiration of thyroid nodules. J Otolaryngol Head Neck Surg. 2014;43(1):48. https://doi.org/10.1186/s40463-014-0048-0.
Article
PubMed
PubMed Central
Google Scholar
Nadauld L, Regan JF, Miotke L, Pai RK, Longacre TA, Kwok SS, et al. Quantitative and sensitive detection of cancer genome amplifications from formalin fixed paraffin embedded tumors with droplet digital PCR. Transl Med (Sunnyvale). 2012;2(2):1000107.
Article
PubMed Central
Google Scholar
Whale AS, Huggett JF, Cowen S, Speirs V, Shaw J, Ellison S, et al. Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res. 2012;40(11):e82. https://doi.org/10.1093/nar/gks203.
Article
CAS
PubMed
PubMed Central
Google Scholar
Biron VL, Matkin A, Kostiuk M, Williams J, Cote DW, Harris J, et al. Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction. J Otolaryngol Head Neck Surg. 2018;47(1):60. https://doi.org/10.1186/s40463-018-0299-2.
Article
PubMed
PubMed Central
Google Scholar
Altman D, Machin D, Bryant T, Gardner M. Statistics with confidence. Hoboken: Wiley; 2013.
Google Scholar
Edge SB et al. American Joint Committee on Cancer. AJCC cancer staging manual 8th ed. 2017.
Google Scholar
Xing M. Prognostic genetic marker-guided risk stratification and management of thyroid cancer. Endocrinol Metab Clin N Am. 2019;48(1):109–24. https://doi.org/10.1016/j.ecl.2018.11.007.
Article
Google Scholar
Zhang M, Lin O. Molecular testing of thyroid nodules: a review of current available tests for fine-needle aspiration specimens. Arch Pathol Lab Med. 2016;140(12):1338–44. https://doi.org/10.5858/arpa.2016-0100-RA.
Article
CAS
PubMed
Google Scholar
Bidshahri R, Attali D, Fakhfakh K, McNeil K, Karsan A, Won JR, et al. Quantitative detection and resolution of BRAF V600 status in colorectal Cancer using droplet digital PCR and a novel wild-type negative assay. J Mol Diagn. 2016;18(2):190–204. https://doi.org/10.1016/j.jmoldx.2015.09.003.
Article
CAS
PubMed
Google Scholar
Olmedillas-López S, García-Arranz M, García-Olmo D. Current and emerging applications of droplet digital PCR in oncology. Mol Diagn Ther. 2017;21(5):493–510. https://doi.org/10.1007/s40291-017-0278-8.
Article
CAS
PubMed
Google Scholar
Qu N, Zhang L, Ji Q, Zhu YX, Wang ZY, Shen Q, et al. Number of tumor foci predicts prognosis in papillary thyroid cancer. BMC Cancer. 2014;14(1):914. https://doi.org/10.1186/1471-2407-14-914.
Article
PubMed
PubMed Central
Google Scholar
Vuong HG, Altibi AMA, Duong UNP, Hassell L. Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-a meta-analysis. Clin Endocrinol. 2017;87(5):411–7. https://doi.org/10.1111/cen.13413.
Article
CAS
Google Scholar
Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014;32(25):2718–26. https://doi.org/10.1200/JCO.2014.55.5094.
Article
CAS
PubMed
PubMed Central
Google Scholar
Song YS, Yoo SK, Kim HH, Jung G, Oh AR, Cha JY, et al. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer. Endocr Relat Cancer. 2019;26(6):629–41. https://doi.org/10.1530/ERC-17-0562.
Article
CAS
PubMed
Google Scholar
Krasner JR, Alyouha N, Pusztaszeri M, Forest VI, Hier MP, Avior G, et al. Molecular mutations as a possible factor for determining extent of thyroid surgery. J Otolaryngol Head Neck Surg. 2019;48(1):51. https://doi.org/10.1186/s40463-019-0372-5.
Article
PubMed
PubMed Central
Google Scholar
Kay-Rivest E, Tibbo J, Bouhabel S, Tamilia M, Leboeuf R, Forest V-I, et al. The first Canadian experience with the Afirma® gene expression classifier test. J Otolaryngol Head Neck Surg. 2017;46(1):25. https://doi.org/10.1186/s40463-017-0201-7.
Article
PubMed
PubMed Central
Google Scholar
Hysek M, Jatta K, Hellgren LS, Stenman A, Larsson C, Zedenius J, et al. Spatial distribution patterns of clinically relevant TERT promoter mutations in follicular thyroid tumors of uncertain malignant potential: advantages of the digital droplet PCR technique. J Mol Diagn. 2021;23(2):212–22. https://doi.org/10.1016/j.jmoldx.2020.10.016.
Article
CAS
PubMed
Google Scholar
Stenman A, Hysek M, Jatta K, Bränström R, Darai-Ramqvist E, Paulsson JO, et al. TERT promoter mutation spatial heterogeneity in a metastatic follicular thyroid carcinoma: implications for clinical work-up. Endocr Pathol. 2019;30(3):246–8. https://doi.org/10.1007/s12022-019-09580-7.
Article
CAS
PubMed
Google Scholar
Jalink M, Ge Z, Liu C, Björkholm M, Gruber A, Xu D. Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA. Biochem Biophys Res Commun. 2007;353(4):999–1003. https://doi.org/10.1016/j.bbrc.2006.12.149.
Article
CAS
PubMed
Google Scholar
Hellgren LS, Olsson A, Kaufeldt A, et al Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool? J Clin Pathol. Published Online First: 19 May 2021. https://doi.org/10.1136/jclinpath-2021-207631.